Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 24, 2001
Neuroendocrine small cell carcinoma of the uterine cervix: what disease? What treatment? Report of ten cases and a review of the literature
S Delaloge, P Pautier, P Kerbrat, et al.
Virology Journal
|
April 20, 2017
Tissue tropisms, infection kinetics, histologic lesions, and antibody response of the MR766 strain of Zika virus in a murine model
Anna B Kawiecki, E Handly Mayton, M Fausta Dutuze, et al.
American Journal of Clinical Oncology
|
April 1, 1994
Acute antiemetic efficacy and safety of dolasetron mesylate, a 5-HT3 antagonist, in cancer patients treated with cisplatin. European Dolasetron Study Group
T Conroy, P Cappelaere, M Fabbro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Phase II trial of iproplatin in advanced squamous cell carcinoma of the head and neck, oesophagus and lung
P Cappelaere, N Guiochet, P Bastit, et al.
Bulletin Du Cancer
|
January 1, 1991
[Study of high doses of carboplatin as a first choice in the therapy of advanced ovarian cancers]
P Kerbrat, J F Héron, J P Guastalla, et al.
Bulletin Du Cancer
|
January 1, 1991
[Study of vinorelbine (V) combined with hexamethylmelamine (H) (combination V-H) in adenocarcinoma of the ovary: results a phase I-IIA trial, NHO-88, of ARTAC "ovarian" group]
G Pinon, M C Pinel, M J Goudier, et al.
Seminars in Oncology
|
April 1, 1989
Navelbine in advanced ovarian epithelial cancer: a study of the French oncology centers
M J George, J F Heron, P Kerbrat, et al.
Cancer Chemotherapy and Pharmacology
|
November 16, 2006
Variations in schedules of ifosfamide administration: a better understanding of its implications on pharmacokinetics through a randomized cross-over study
E G C Brain, K Rezai, S Weill, et al.
Bulletin Du Cancer
|
October 15, 1998
[Mitomycin-vinorelbine combination as second-line chemotherapy in metastatic cancer of the breast]
H Bourgeois, F Turpin, M Bouchada, et al.
Cancer Chemotherapy and Pharmacology
|
December 29, 2000
Population pharmacokinetics of topotecan: intraindividual variability in total drug
A Montazeri, M Boucaud, F Lokiec, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 24, 2001
Neuroendocrine small cell carcinoma of the uterine cervix: what disease? What treatment? Report of ten cases and a review of the literature
S Delaloge, P Pautier, P Kerbrat, et al.
Virology Journal
|
April 20, 2017
Tissue tropisms, infection kinetics, histologic lesions, and antibody response of the MR766 strain of Zika virus in a murine model
Anna B Kawiecki, E Handly Mayton, M Fausta Dutuze, et al.
American Journal of Clinical Oncology
|
April 1, 1994
Acute antiemetic efficacy and safety of dolasetron mesylate, a 5-HT3 antagonist, in cancer patients treated with cisplatin. European Dolasetron Study Group
T Conroy, P Cappelaere, M Fabbro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Phase II trial of iproplatin in advanced squamous cell carcinoma of the head and neck, oesophagus and lung
P Cappelaere, N Guiochet, P Bastit, et al.
Bulletin Du Cancer
|
January 1, 1991
[Study of high doses of carboplatin as a first choice in the therapy of advanced ovarian cancers]
P Kerbrat, J F Héron, J P Guastalla, et al.
Bulletin Du Cancer
|
January 1, 1991
[Study of vinorelbine (V) combined with hexamethylmelamine (H) (combination V-H) in adenocarcinoma of the ovary: results a phase I-IIA trial, NHO-88, of ARTAC "ovarian" group]
G Pinon, M C Pinel, M J Goudier, et al.
Seminars in Oncology
|
April 1, 1989
Navelbine in advanced ovarian epithelial cancer: a study of the French oncology centers
M J George, J F Heron, P Kerbrat, et al.
Cancer Chemotherapy and Pharmacology
|
November 16, 2006
Variations in schedules of ifosfamide administration: a better understanding of its implications on pharmacokinetics through a randomized cross-over study
E G C Brain, K Rezai, S Weill, et al.
Bulletin Du Cancer
|
October 15, 1998
[Mitomycin-vinorelbine combination as second-line chemotherapy in metastatic cancer of the breast]
H Bourgeois, F Turpin, M Bouchada, et al.
Cancer Chemotherapy and Pharmacology
|
December 29, 2000
Population pharmacokinetics of topotecan: intraindividual variability in total drug
A Montazeri, M Boucaud, F Lokiec, et al.
Page
of 6